AvePoint (AVPT) Cash & Equivalents (2019 - 2026)

AvePoint has disclosed Cash & Equivalents across 8 years of filings, most recently posting $444.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 26.36% year-over-year to $444.1 million; the TTM figure through Mar 2026 stood at $444.1 million (up 26.36% YoY), while the FY2025 annual figure was $481.1 million, up 65.46% from the prior year.
• Cash & Equivalents retreated to $444.1 million in Q1 2026, from $481.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for AVPT reached as high as $481.1 million in Q4 2025 and fell as low as $65.1 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $227.2 million (2022), against an average of $272.2 million.
• The widest YoY moves for Cash & Equivalents: up 56364.89% in 2022, down 16.46% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $227.2 million in 2022, then fell by 1.77% to $223.2 million in 2023, then jumped by 30.28% to $290.7 million in 2024, then soared by 65.46% to $481.1 million in 2025, then declined by 7.68% to $444.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $444.1 million, $481.1 million, and $471.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.